DYAD is a London-based healthcare AI company developing technology to improve the way clinical information is understood and transferred across healthcare. Its proprietary AI system, GENIE, turns unstructured clinical information into structured, usable healthcare data. In primary care, GENIE powers BetterLetter, an AI-powered clinical coding platform that has processed more than five million documents to date. DYAD's technology is already used by more than 200 GP surgeries, with the company supporting the processing of approximately 500,000 clinical letters each month.
DYAD: Venture Capital Funding History
DYAD
DYAD
- Health
- London, United Kingdom
- £7.5m
- dyad.ai
- Update Information
More venture news
- 5 Nov 2026

NayaraNayara closes a pre-seed round led by SFC Capital to support patients between appointments with AI companions
Pre-seedHealth - 4 Nov 2026

SurghiveSurghive raises a £320k seed round led by SFC Capital to train surgeons on any robotic surgery system
SeedHealth - 3 Nov 2026

1nhaler1nhaler lands a £2m follow-on round led by Archangels to test its pop-up cardboard asthma inhaler in patients
Follow-onHealth
